Evidence map›Paper›PMID 33580925›Full record

ReviewIndian journal of dermatology, venereology and leprology

Management of Darier disease: A review of the literature and update.

Roger N Haber, Nicole G Dib

Open access · diamondAbstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of dermatology, venereology and leprology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Case of Darier's Disease with a Novel Missense Mutation inClinical, cosmetic and investigational dermatology · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Roger N HaberDepartment of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.
Nicole G DibDepartment of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.
Saint George Hospital · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Darier disease (DD) is a rare type of inherited keratinizing disorder with no definitive therapeutic approach. The objective of this study is to provide a detailed literature review of all the available treatment modalities of Darier disease, including those that are both surgical and non surgical, to compare their efficacies and to propose a novel therapeutic approach. A complete search of the literature for all articles describing the different treatments of Darier disease, with no restrictions on patients' ages, gender or nationalities, was performed with the use of PubMed. A total of 68 articles were included in the study: 3 prospective studies, 44 case reports/case series and 21 letters/correspondences/clinical images. The treatments described were topical, oral or physical. Retinoids (isotretinoin, tazarotene and adapalene) and fluorouracil were the two most effective topical treatments. Oral retinoids were the most effective oral therapy and were prescribed in the cases of generalized Darier disease. For localized and resistant skin lesions, physical therapies including surgical excision, dermabrasion and CO2 laser ablation were the first line choices. Limitations of this article include the inability to verify the accuracy of the published data, the relatively small sample size, the absence of randomized controlled clinical trials and possible unidentified confounding factors in various studies. In every therapeutic approach to Darier disease, consideration of patient comorbidities, disease distribution, severity and treatment accessibility is essential. Large and randomized clinical trials are necessary for the comparison of the efficacy and the safety of all the treatments of Darier disease and settling a consensus for management.

Indexed as

Administration, TopicalAlgorithmsBotulinum ToxinsCetirizineCyclosporineDarier DiseaseDermabrasionDiclofenacDihydroxycholecalciferolsDoxycyclineDrug CombinationsElectrosurgeryEthinyl EstradiolFatty AcidsFluorouracilGlucocorticoids1 alpha,24-dihydroxyvitamin D3Botulinum ToxinsCetirizineCyclosporineDiclofenacDihydroxycholecalciferolsDoxycyclineDrug CombinationsEthinyl Estradiolethinyl estradiol, levonorgestrel drug combinationFatty AcidsFluorouracilGlucocorticoidsLevonorgestrelMagnesium ChlorideNaltrexoneRetinoidsTacrolimusDarierlasersurgerysystemictopicaltreatment

Identifiers

PMID33580925
OpenAlexW3127814017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.